Novartis AG
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
METHODS OF TREATMENT OF CANCER WITH ANTIBODY-IL-2 ENGRAFTED PROTEINS
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Big Pharma is buying its way out of the patent cliff, while Novartis AG (NYSE:NVS) is trying to out-develop it. A Record Year for Biotech Deals The scale of that buying activity appears in this year’s deal totals. Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far […]
Novartis: The Buy Thesis Is Back (Rating Upgrade)
Novartis AG ended Q2 on a high note as oncology offset Entresto weakness; 2026 guidance reaffirmed. Read why NVS stock is upgraded to a buy.
Key People
No individuals linked to this entity yet.
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro